ClosedOpportunity RFA-FD-13-030

In vitro-In vivo Correlations of Parenteral Microsphere Drug Products

Food and Drug Administration · Department of Health and Human Services

At a glance

In vitro-In vivo Correlations of Parenteral Microsphere Drug Products is a closed federal cooperative agreement opportunity from the Food and Drug Administration (Department of Health and Human Services). The application deadline was June 4, 2013. Individual awards are listed as $5K – $500K, with about 1 award expected and $500K in total estimated funding. Applicant types listed as eligible include state governments, county governments, city or township governments, special district governments, independent school districts and 9 more. Cost sharing is not required. It is funded under Assistance Listing 93.103 (Food and Drug Administration Research).

Summary assembled from the official notice's fields. The official notice governs.

Key facts

Posted: Apr 18, 2013
Close date: Jun 4, 2013
Award floor: $5,000
Award ceiling: $500,000
Est. total funding: $500,000
Expected awards: 1
Cost sharing: Not required
Funding instrument: Cooperative Agreement
Opportunity category: Discretionary

Who can apply

State governments
County governments
City or township governments
Special district governments
Independent school districts
Public colleges & universities
Federally recognized tribal governments
Native American tribal organizations
501(c)(3) nonprofits
Nonprofits without 501(c)(3) status
Private colleges & universities
For-profit organizations (not small businesses)
Small businesses
Others (see notice)

Additional information on eligibility (from the notice)

Higher Education Institutions Public/State Controlled Institutions of Higher Education Private Institutions of Higher Education The following types of Higher Education Institutions are always encouraged to apply for FDA support as Public or Private Institutions of Higher Education: Hispanic-serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISIs) Nonprofits Other Than Institutions of Higher Education Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education) Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education) For-Profit Organizations Small Businesses For-Profit Organizations (Other than Small Businesses) Governments State Governments County Governments City or Township Governments Special District Governments Indian/Native American Tribal Governments (Federally Recognized) Indian/Native American Tribal Governments (Other than Federally Recognized) Eligible Agencies of the Federal Government U.S. Territory or Possession Other Independent School Districts Public Housing Authorities/Indian Housing Authorities Native American Tribal Organizations (other than Federally recognized tribal governments) Faith-based or Community-based Organizations Regional Organizations Non-domestic (non-U.S.) Entities (Foreign Institutions) Foreign Institutions Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

The purpose of this study is to investigate in vitro-in vivo correlations of parenteral microspheres. The encapsulated agent may be a small molecule or peptide, and the dosage form should be an injectable. An in vitro dissolution test which correlates with in vivo absorption should be investigated. In vivo studies should be conducted in a suitable animal model.The results from this project will help to understand the release mechanisms of microspheres and how in vitro studies could be used to predict in vivo bioavailability.

Additional information from the agency ↗

Assistance Listing

What is an ALN?

93.103Food and Drug Administration ResearchProgram →

Reported obligations under ALN 93.103

Historical data · not a prediction

FY18

$173M

FY19

$199M

FY20

$212M

FY21

$219M

FY22

$256M est.

FY23

$247M est.

Source: SAM.gov Assistance Listing 93.103. Program-wide totals, not awards from this specific opportunity.

Agency contact (as published)

Food & Drug Administration
Jennerfer.Torres-Hernandez@fda.hhs.gov
301-443-5869

Quick answers

Who is eligible to apply for “In vitro-In vivo Correlations of Parenteral Microsphere Drug Products”?

The official notice lists these applicant types as eligible: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public colleges & universities, Federally recognized tribal governments, Native American tribal organizations, 501(c)(3) nonprofits, Nonprofits without 501(c)(3) status, Private colleges & universities, For-profit organizations (not small businesses) and 2 more. Additional restrictions may apply; review the full notice.

How much funding is available through “In vitro-In vivo Correlations of Parenteral Microsphere Drug Products”?

Per the notice, individual awards are listed as $5k – $500k, total estimated program funding is $500,000 and the agency expects to make about 1 awards.

How do I apply for “In vitro-In vivo Correlations of Parenteral Microsphere Drug Products”?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity RFA-FD-13-030), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.

ForecastedALN 93.103